Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration [Docket No. 2005N-0178]
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Notice.
 SUMMARY: The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
 DATES: Fax written comments on the collection of information by November 7, 2005.
 ADDRESSES: OMB is still experiencing significant delays in the regular mail, including first class and express mail, and messenger deliveries are not being accepted.  To ensure that comments on the information collection are received, OMB recommends that comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn:  Fumie Yokota, Desk Officer for FDA, FAX:  202-395-6974.
 FOR FURTHER INFORMATION CONTACT: Peggy Robbins, Office of Management Programs (HFA 250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1223.


SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. Under the regulations implementing the Federal Import Milk Act (FIMA) (21 U.S.C. 141-149), milk or cream may be imported into the United States only by the holder of a valid import milk permit. Before such permit is issued:  (1) All cows from which import milk or cream is produced must be physically examined and found healthy; (2) if the milk or cream is imported raw, all such cows must pass a tuberculin test; (3) the dairy farm and each plant in which the 
                    ( print page 58710)
                    milk or cream is processed or handled must be inspected and found to meet certain sanitary requirements; (4) bacterial counts of the milk at the time of importation must not exceed specified limits; and (5) the temperature of the milk or cream at time of importation must not exceed 50° F. In addition, the regulations in part 1210 (21 CFR part 1210) require that dairy farmers and plants maintain pasteurization records (§ 1210.15) and that each container of milk or cream imported into the United States bear a tag with the product type, permit number, and shipper's name and address (§ 1210.22). In the 
                    **Federal Register**
                     of  May 31, 2005 (70 FR 30951), FDA published a 60-day notice requesting public comment on the information collection provisions. FDA received one letter in response, which contained several comments and suggestions.  These suggestions and FDA's responses follow. The comment stated that the collection of information in forms FDA 1815, FDA 1993, FDA 1994, FDA 1995, FDA 1996, and FDA 1997 is necessary and that most of these forms provide practical information.  However, the comment requested a number of changes to the forms.  First, the comment suggested that certification of tuberculosis-free status in Form FDA 1815 and Form FDA 1994 should be done in a manner consistent with the U.S. Department of Agriculture's Animal Plant Health and Inspection Service (APHIS) guidelines entitled “Bovine Tuberculosis Eradication Uniform Methods and Rules” (APHIS 91-45-011).  Another comment suggested that that Form FDA 1815 and Form FDA 1995  include a requirement that the submitter certify that the dairy cows are free from brucellosis and that the certification of brucellosis-free status should be done in a manner consistent with the APHIS guidelines published in the document entitled “Brucellosis Eradication:   Uniform Methods and Rules” (APHIS 91-45-013). FDA agrees that, where possible, Federal agencies should act in a consistent manner.  However, FDA declines to make the suggested changes to its forms because such changes are not necessary.  The two referenced documents are published by APHIS as part of its national animal disease eradication efforts undertaken by the National Center for Animal Health Programs under the statutory authority provided by the Animal Health Protection Act (7 U.S.C. 8301-8320).   These are domestic programs in the United States which are designed to address the general health status of U.S. domestic cattle.  Under the statutory authority provided by FIMA, FDA regulates all foreign-produced milk and cream imported into the United States.  FIMA requires certification of the general health of the animal, which certification is obtained by FDA on Form FDA 1995.  Although the two statutory authorities may differ, the practices presented in the APHIS documents already are being followed by FDA.  FDA considers the status of the brucellosis and tuberculosis control programs in the country offering milk for importation into the United States and bases its acceptance decision on that status. Another comment stated that Form FDA 1996 and Form FDA 1997 do not provide practical information and should be made consistent with Form FDA 2359a, which, the comment states, is “utilized to ensure milk sanitation standards are met at the farm level.” FDA disagrees that Form FDA 1996, “Dairy Farm Sanitation Report,” and Form FDA 1997, “Score Card for Sanitary Inspection of Milk Plants,” do not provide practical information.  The information collected on these two forms is used by the agency in determining whether the imported milk or cream offered for import meet FIMA's requirements for sanitary inspections of dairy farms and plants (21 U.S.C. 142).  FDA also disagrees that the two forms should be made consistent with Form FDA 2359a because that form is used domestically for inspection of facilities producing Grade “A” milk products.  FDA does not use it for inspections of facilities producing manufacturing-grade milk domestically.  Thus, it would be inappropriate for FDA to use it for inspection of foreign facilities manufacturing non-Grade “A” milk products. The comment also opposed electronic submission of the forms and suggested that several changes should be made to the requirements of FIMA and the agency's related Compliance Policy Guide. These comments are outside the scope of the four collection of information topics on which the notice solicits comments and, thus, will not be addressed here. FDA estimates the burden of this collection of information as follows: **Table 1.— Estimated Annual Reporting Burden**1
Form No.
21 CFR Section
No. of 
                             Respondents
Annual Frequency 
                             per Response
Total Annual 
                             Responses
Hours per 
                             Response
Total HoursFDA 1815/Permits granted on certificates
1210.23
8
1
8
0.5
4.0FDA 1993/Application of 
                             permit
1210.20
8
1
8
0.5
4.0FDA 1994/Tuberculin test
1210.13
1
1
1
0.5
0.5FDA 1995/Physical 
                             examination of cows
1210.12
1
1
1
0.5
0.5FDA 1996/Sanitary inspection of dairy farms
1210.11
8
200
1,600
1.5
2,400( print page 58711)FDA 1997/Sanitary 
                             inspections of plants
1210.14
8
1
8
2.0
16.0Totals





2,425.01
                        There are no capital costs or operating and maintenance costs associated with this collection of information.
 **Table 2.—Estimated Annual Recordkeeping Burden**1
21 CFR Section
No. of 
                             Recordkeepers
Annual Frequency 
                             per  Record
Total Annual 
                             Records
Hours per 
                             Recordkeeper
Total Hours1210.15
8
1
8
.05
0.401
                        There are no capital costs or operating and maintenance costs associated with this collection of information.
 These estimates are based on the number of current permit holders and the number of inquiries that FDA has received regarding requests for applications in the past 3 years. No burden has been estimated for the tagging requirement in § 1210.22 because the information on the tag is either supplied by FDA (permit number) or is disclosed to third parties as a usual and customary part of the shipper's normal business activities (type of product, shipper's name and address). Under 5 CFR 1320.3(c)(2), the public disclosure of information originally supplied by the Federal Government to the recipient for the purpose of disclosure to the public is not a collection of information. Under 5 CFR 1320.3(b)(2)), the time, effort, and financial resources necessary to comply with a collection of information are excluded from the burden estimate if the reporting, recordkeeping, or disclosure activities needed to comply are usual and customary because they would occur in the normal course of activities. Low burden has been estimated for Forms FDA 1994 and 1995 because they are not are not used often. The Secretary of Health and Human Services has the discretion to allow Form FDA 1815, a duly certified statement signed by an accredited official of a foreign government, to be submitted in lieu of Forms FDA 1994 and 1995. To date, Form FDA 1815 has been submitted in lieu of these forms. Dated: October 3, 2005. Jeffrey Shuren, Assistant Commissioner for Policy.


[FR Doc. 05-20148 Filed 10-6-05; 8:45 am] BILLING CODE 4160-01-S